Physician

Chandana Javvaji, M.D.

According to 2025 Medicare claims, Chandana Javvaji, M.D. (NPI: 1821437716) practices hematology/oncology in the Sioux City, IA-NE-SD market, with the plurality of this provider's patient population coming from Woodbury, IA. This provider's primary affiliated billing organization is SIOUXLAND REGIONAL CANCER CENTER (NPI: 1114904604; TIN: 421411233) and primary practice location at 51101-1733. Javvaji is affiliated with the Prairie Vista Care Organization (ACO ID: A3578), Bryan Health Connect ACO, LLC (ACO ID: A4573), Avera Prairie View ACO (ACO ID: A4692), Caravan Health ACO 50 LLC (ACO ID: A5160), Main Street Rural Health Hawthorn ACO LLC (ACO ID: A5438), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Javvaji's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 888 traditional Medicare patients, billed 186,743 HCPCS/CPT codes, and received $4,495,256 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,604 prescription claims across 287 beneficiaries totaling $3,243,535 in drug costs, led by Imbruvica (Ibrutinib). 2023 DME data shows 11 claims. Open Payments data shows 21 records totaling $383. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $524,434 to $4,495,256. Similarly, Part D prescription costs have risen steadily, from $50,819 to $3,243,535. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	371	29,870	$524,434
2020	670	117,949	$2,081,461
2021	721	112,958	$2,106,787
2022	734	139,315	$2,712,362
2023	790	136,860	$2,890,099
2024	888	186,743	$4,495,256

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	11	23	$50,819
2016	28	148	$15,828
2017	31	182	$249,500
2018	56	277	$494,304
2019	117	312	$330,768
2020	167	900	$1,145,105
2021	192	1,222	$1,316,635
2022	238	1,275	$2,300,297
2023	280	1,722	$4,062,761
2024	287	1,604	$3,243,535

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	29	$2,774
2021	N/R	24	$1,835
2022	N/R	N/R	N/R
2023	N/R	11	$499
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	400	704	$86
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	594	1,082	$12
80053	Blood test, comprehensive group of blood chemicals	733	1,619	$10
36415	Insertion of needle into vein for collection of blood sample	645	1,345	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	760	1,769	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Imbruvica	Ibrutinib	58	1,624	$912,065
Calquence	Acalabrutinib Maleate	42	1,260	$631,260
Ibrance	Palbociclib	20	560	$324,757
Xtandi	Enzalutamide	22	660	$292,331
Brukinsa	Zanubrutinib	12	360	$180,608

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	21	$383	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Chandana Javvaji, M.D.?

Tedicare shows public-source Medicare data for Chandana Javvaji, M.D. (NPI 1821437716), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Chandana Javvaji, M.D. have ACO affiliation data?

Chandana Javvaji, M.D. is shown with ACO affiliation data for Prairie Vista Care Organization (MSSP, ACO ID A3578), Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573), Avera Prairie View ACO (MSSP, ACO ID A4692), Caravan Health ACO 50 LLC (MSSP, ACO ID A5160), Main Street Rural Health Hawthorn ACO LLC (MSSP, ACO ID A5438), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Chandana Javvaji, M.D.?

Chandana Javvaji, M.D. is linked to SIOUXLAND REGIONAL CANCER CENTER (billing NPI 1114904604) in the available physician profile data.

Does Chandana Javvaji, M.D. have Open Payments data?

Chandana Javvaji, M.D. has 21 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.